Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 250K - 250K
Notice Type:
Contract Notice
Published Date:
19 April 2023
Closing Date:
17 May 2023
Location(s):
FRI12 Gironde (FR FRANCE)
Description:
Surgical and percutaneous heart valves Part 2 for the benefit of the regional group of orders -

Consultation initiated by a group of orders. The coordinator of the group of orders is: University Hospital of Bordeaux M the director (support establishment of the Ght Alliance Gironde). It is responsible for the award, signature and notification of the framework agreement. Each member (Support Institutions and Party) must monitor the implementation of the Framework Agreement. The framework agreement shall be concluded with a maximum in quantity for all lots, with the exception of lot 2 which includes a minimum and a maximum in quantity. It was passed pursuant to Articles L2125-1 1°, R. 2162-1 to R. 2162-6, R. 2162-13 and R. 2162-14 of the Public Order Code. The framework agreement will be implemented through the issuance of purchase orders. Each lot will be awarded separately. The maximums are expressed in quantity in the consultation documents

aortic duct with mechanical valve

Aortic duct with mechanical valve -Maximum Qty over 12 months: 7estimated amount Ht of the lot for the total duration of the contract: 17 518,00 Euro (S) (H.T.). The maximums are expressed in quantity in the consultation documents

Percutaneous clip system for tricuspid valve

Percutaneous clip system for tricuspid valve -Qty mini over 12 months: 2 -Qty maximum over 12 months: 11 estimated amount HT of the lot for the total duration of the contract: 230 000,00 Euro (S) (H.T.). The maximums are expressed in quantity in the consultation documents

Download full details as .pdf
The Buyer:
chu de bordeaux
CPV Code(s):
33182220 - Cardiac valve
33600000 - Pharmaceutical products